Author Archives

Daniel HougendoblerDaniel Hougendobler
dah93@law.georgetown.edu

Public Health Emergency Preparedness in Action: The Medical Response to the November Paris Terror Attacks

By | Leave a Comment

On November 13, Paris experienced the worst terrorist attack in the city’s history. In coordinated attacks across the city, terrorists detonated suicide vests and gunned down concertgoers. In the end 130 people were killed and more than 350 wounded—many seriously. Mass casualty, multi-site terror attacks pose an extraordinary challenge to health system capacity. An influx […]

Read More

Posted in Global Health; Tagged: , , , .


Behind Recent Drug Price Gouging, a Bad CEO and an Even Worse Legal System

By | Leave a Comment

It’s been a rough week for bad executives. Volkwagen’s CEO, Martin Winterkorn, resigned after investigators discovered that the carmaker had installed software that allowed its vehicles to pass emissions tests, while during normal operation they spewed out pollutants far beyond legal limits. Another executive received a 28-year prison sentence for deliberately shipping tainted peanut butter […]

Read More

Posted in FDA, National Healthcare; Tagged: , , , , .


Remembering Dr. Frances Oldham Kelsey, the Regulator Who Saved a Generation of American Children

By | Leave a Comment

In the late 1950s, a new over-the-counter sedative, thalidomide was introduced in Germany. At the time, it was the only non-barbiturate sedative on the market and it was marketed as an extraordinarily safe sleeping aid. The drug company “advertised their product as ‘completely safe’ for everyone, including mother and child, ‘even during pregnancy,’ as its […]

Read More

Posted in FDA, National Healthcare; Tagged: , , .


Can Biohacking Solve the Global Insulin Shortage?

By | Leave a Comment

For many diabetics, access to insulin can mean the difference between life and death. However, this vital product is often exorbitantly expensive, particularly for those living in low- and middle-income countries. As a result, many needlessly suffer and die from a manageable disease. One study estimates that the global prevalence of diabetes will rise from […]

Read More

Posted in Global Health; Tagged: , , , .


What We Know (and Don’t Know) About the South Korean MERS-CoV Outbreak

By | Leave a Comment

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been circulating since at least April 2012. Since then it has been confined largely to the Middle East (with some notable exceptions). The two weeks have seen the largest outbreak of the disease outside of the region, with at least 41 MERS-CoV cases and 4 deaths in South […]

Read More

Posted in Global Health; Tagged: , , , , .


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.